Biosplice

SpliceBio

The company develops gene therapies using protein splicing technology to deliver large genes for patients with genetic diseases such as Stargardt disease.

BYOMass

This company develops biologic and small molecule drugs targeting the TGF-beta superfamily to treat metabolic, fibrotic and age-related diseases for patients with unmet needs.

Skeletalis

This biotechnology company develops bone-targeted small-molecule therapies for patients with osteoporosis and other musculoskeletal diseases.

Biotheryx

The company develops protein degrader medicines for patients with cancer and inflammatory diseases.

Myosin Therapeutics

This biopharmaceutical company develops small molecule therapies targeting molecular nanomotors to treat aggressive cancers and neurological disorders for patients with unmet medical needs.

Kronos Bio

This biopharmaceutical company develops small molecule therapeutics targeting transcription factors for patients with cancer and autoimmune diseases.

Biopharmaceutical company

This firm develops small molecule drugs targeting protein regulatory sites to treat patients with cancer and autoimmune diseases.

Arrakis Therapeutics

This biopharmaceutical company develops oral, small-molecule medicines that target RNA to treat patients with cancer, cardiovascular conditions, neurodegeneration and rare genetic diseases.